Skip to Main content Skip to Navigation
Journal articles

Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease

Abstract : NAFLD is a frequent disease that affects 25% of the worldwide population. There is no specific diagnostic test for NAFLD, and the diagnosis mainly relies on the elimination of the other causes of chronic liver diseases with liver biopsy kept for unsure diagnoses. Non-invasive tests are now available to assess NAFLD severity and therefore to help physicians decide on the patient management and follow-up. These non-invasive tests can also be used to define pathways that organize referrals from primary care and diabetology clinics to the liver specialist, with the ambition to improve the screening of asymptomatic patients with NAFLD and advanced liver disease. NAFLD being the liver expression of the metabolic syndrome, physicians need also take care to screen for diabetes and to evaluate the cardiovascular risk in those patients. These recommendations from the French Association for the Study of the Liver (AFEF) aim at providing guidance on the following questions: how to diagnose NAFLD; how non-invasive tests should be used to assess NAFLD severity; how to follow patients with NAFLD; when to perform liver biopsy in NAFLD; and how to decide referral to the liver specialist for a patient with NAFLD.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03651877
Contributor : Odile Malbec Connect in order to contact the contributor
Submitted on : Tuesday, April 26, 2022 - 10:20:14 AM
Last modification on : Wednesday, September 28, 2022 - 4:20:12 PM
Long-term archiving on: : Wednesday, July 27, 2022 - 6:36:30 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Jérôme Boursier, Maeva Guillaume, Charlotte Bouzbib, Adrien Lannes, Raluca Pais, et al.. Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2022, 46 (1), pp.101769. ⟨10.1016/j.clinre.2021.101769⟩. ⟨inserm-03651877⟩

Share

Metrics

Record views

30